RE:MD&A tidbits To the morons claiming declining sales and other patently false idiocy... again, straight from the MD&A
maryhill wrote: Demand has been strong for both brands, often times resulting in WeedMD being unable to keep up with demand in its adult-use and medical channels. With the increase in production capacity in Q4 2019, WeedMD expects to be able to deliver significantly more product to its current distribution channels in 2020.
WeedMD continues to see increased sales momentum in its Color Cannabis brand which was launched in June 2019. Measured against other consolidated LP brands, WeedMD sold 3.3% of all flower kilograms sold in Ontario in Q3, while its ranking measured by dollar sales moved from 17th place in Q2 to 7th place in Ontario in Q3
In 2020, under the WeedMD and Color Cannabis brands, the Company will offer flower, oil tinctures, pre-rolls, gel capsules, vapes and new concentrate formats while also unveiling two new internally created brands in Q1 2020 allowing WeedMD to appeal to a wider proportion of consumers.
WeedMD and CX Industries is currently in the development of new flower and Cannabis 2.0 products including prerolls, shredded flower (Ready to Roll™), gel capsules, THC & CBD distillate vapes, as well as other concentrate products. WeedMD intends to launch its new products early in 2020 with the introduction of Cannabis 2.0 regulations from Health Canada and individual provinces.
As at September 30, 2019, the Company employed a total of 212 people (September 30, 2018: 102 people), of which 17% (Q3 2018: 20%) were employed in support service departments reflected in general and administrative expenses, such as human resources, finance, information technology, customer service and sales & marketing.